{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:01:42Z","timestamp":1780736502123,"version":"3.54.1"},"reference-count":24,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.3171\/2021.6.focus21374","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T07:40:01Z","timestamp":1630482001000},"page":"E10","source":"Crossref","is-referenced-by-count":1,"title":["Editorial. Growing research: how neurosurgeons can lead the development of nonsurgical treatments for moyamoya disease"],"prefix":"10.3171","volume":"51","author":[{"given":"Edward R.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u20131237.1929757510.1056\/NEJMra0804622"},{"issue":"9","key":"b2","series-title":"Dev Med Child Neurol","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/dmcn.12708","article-title":"Moyamoya: defining current knowledge gaps","volume":"57","author":"Ganesan V","year":"2015","unstructured":"Ganesan V, Smith ER. Moyamoya: defining current knowledge gaps. Dev Med Child Neurol. 2015;57(9):786\u2013787.10.1111\/dmcn.1270825683905"},{"key":"b3","series-title":"JAMA Neurol","article-title":"DIAPH1 Variants in non-East Asian patients with sporadic moyamoya disease","author":"Kundishora AJ","unstructured":"Kundishora AJ, Peters ST, Pinard A,  DIAPH1 Variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol. Published online June 14, 2021. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2021.168134125151"},{"issue":"2","key":"b4","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41436-019-0639-2","article-title":"The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy","volume":"22","author":"Pinard A","year":"2020","unstructured":"Pinard A, Guey S, Guo D,  The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2020;22(2):427\u2013431.10.1038\/s41436-019-0639-231474762"},{"key":"b5","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/GIM.0b013e3181cdd687","article-title":"Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy","volume":"12","author":"Milewicz DM","year":"2010","unstructured":"Milewicz DM, Kwartler CS, Papke CL, Regalado ES, Cao J, Reid AJ. Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet Med. 2010;12:196\u2013203.2013046910.1097\/GIM.0b013e3181cdd687"},{"key":"b6","series-title":"J Hum Genet","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A,  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.2104878310.1038\/jhg.2010.132"},{"key":"b7","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"661952","DOI":"10.3389\/fneur.2021.661952","article-title":"Non-invasive urinary biomarkers in moyamoya disease","volume":"12","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in moyamoya disease. Front Neurol. 2021;12:661952.3386815910.3389\/fneur.2021.661952"},{"issue":"4","key":"b8","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel K","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D,  Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr. 2016;18(4):396\u2013407.10.3171\/2015.12.PEDS15448"},{"issue":"6","key":"b9","series-title":"J Korean Neurosurg Soc","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3340\/jkns.2015.57.6.415","article-title":"Moyamoya biomarkers","volume":"57","author":"Smith ER","year":"2015","unstructured":"Smith ER. Moyamoya biomarkers. J Korean Neurosurg Soc. 2015;57(6):415\u2013421.10.3340\/jkns.2015.57.6.41526180608"},{"issue":"1","key":"b10","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/jcbfm.2010.85","article-title":"Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease","volume":"31","author":"Lee M","year":"2011","unstructured":"Lee M, Guzman R, Bell-Stephens T, Steinberg GK. Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease. J Cereb Blood Flow Metab. 2011;31(1):262\u2013274.2058832110.1038\/jcbfm.2010.85"},{"key":"b11","series-title":"Pediatr Neurol","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2017.08.009","article-title":"The utility of collaterals as a biomarker in pediatric unilateral intracranial arteriopathy","volume":"78","author":"Elbers J","year":"2018","unstructured":"Elbers J, Armstrong D, Benseler SM, Dlamini N, Steinberg GK, Yeom KW. The utility of collaterals as a biomarker in pediatric unilateral intracranial arteriopathy. Pediatr Neurol. 2018;78:27\u201334.2917485710.1016\/j.pediatrneurol.2017.08.009"},{"issue":"3","key":"b12","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2021.6.FOCUS21112","article-title":"The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial","volume":"51","author":"Wang QN","year":"2021","unstructured":"Wang QN, Bao XY, Zou ZX,  The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial. Neurosurg Focus. 2021;51(3):E9.10.3171\/2021.6.FOCUS2111234469867"},{"key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott RM","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u20131237.1929757510.1056\/NEJMra0804622"},{"issue":"9","key":"b2","series-title":"Dev Med Child Neurol","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/dmcn.12708","article-title":"Moyamoya: defining current knowledge gaps","volume":"57","author":"Ganesan V","year":"2015","unstructured":"Ganesan V, Smith ER. Moyamoya: defining current knowledge gaps. Dev Med Child Neurol. 2015;57(9):786\u2013787.10.1111\/dmcn.1270825683905"},{"key":"b3","series-title":"JAMA Neurol","article-title":"DIAPH1 Variants in non-East Asian patients with sporadic moyamoya disease","author":"Kundishora AJ","unstructured":"Kundishora AJ, Peters ST, Pinard A,  DIAPH1 Variants in non-East Asian patients with sporadic moyamoya disease. JAMA Neurol. Published online June 14, 2021. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2021.168134125151"},{"issue":"2","key":"b4","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41436-019-0639-2","article-title":"The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy","volume":"22","author":"Pinard A","year":"2020","unstructured":"Pinard A, Guey S, Guo D,  The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy. Genet Med. 2020;22(2):427\u2013431.10.1038\/s41436-019-0639-231474762"},{"key":"b5","series-title":"Genet Med","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/GIM.0b013e3181cdd687","article-title":"Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy","volume":"12","author":"Milewicz DM","year":"2010","unstructured":"Milewicz DM, Kwartler CS, Papke CL, Regalado ES, Cao J, Reid AJ. Genetic variants promoting smooth muscle cell proliferation can result in diffuse and diverse vascular diseases: evidence for a hyperplastic vasculomyopathy. Genet Med. 2010;12:196\u2013203.2013046910.1097\/GIM.0b013e3181cdd687"},{"key":"b6","series-title":"J Hum Genet","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada F","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A,  A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.2104878310.1038\/jhg.2010.132"},{"key":"b7","series-title":"Front Neurol","doi-asserted-by":"publisher","first-page":"661952","DOI":"10.3389\/fneur.2021.661952","article-title":"Non-invasive urinary biomarkers in moyamoya disease","volume":"12","author":"Sesen J","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in moyamoya disease. Front Neurol. 2021;12:661952.3386815910.3389\/fneur.2021.661952"},{"issue":"4","key":"b8","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","article-title":"Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature","volume":"18","author":"Pricola Fehnel K","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, Zurakowski D,  Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Pediatr. 2016;18(4):396\u2013407.10.3171\/2015.12.PEDS15448"},{"issue":"6","key":"b9","series-title":"J Korean Neurosurg Soc","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3340\/jkns.2015.57.6.415","article-title":"Moyamoya biomarkers","volume":"57","author":"Smith ER","year":"2015","unstructured":"Smith ER. Moyamoya biomarkers. J Korean Neurosurg Soc. 2015;57(6):415\u2013421.10.3340\/jkns.2015.57.6.41526180608"},{"issue":"1","key":"b10","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/jcbfm.2010.85","article-title":"Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease","volume":"31","author":"Lee M","year":"2011","unstructured":"Lee M, Guzman R, Bell-Stephens T, Steinberg GK. Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease. J Cereb Blood Flow Metab. 2011;31(1):262\u2013274.2058832110.1038\/jcbfm.2010.85"},{"key":"b11","series-title":"Pediatr Neurol","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2017.08.009","article-title":"The utility of collaterals as a biomarker in pediatric unilateral intracranial arteriopathy","volume":"78","author":"Elbers J","year":"2018","unstructured":"Elbers J, Armstrong D, Benseler SM, Dlamini N, Steinberg GK, Yeom KW. The utility of collaterals as a biomarker in pediatric unilateral intracranial arteriopathy. Pediatr Neurol. 2018;78:27\u201334.2917485710.1016\/j.pediatrneurol.2017.08.009"},{"issue":"3","key":"b12","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2021.6.FOCUS21112","article-title":"The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial","volume":"51","author":"Wang QN","year":"2021","unstructured":"Wang QN, Bao XY, Zou ZX,  The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial. Neurosurg Focus. 2021;51(3):E9.10.3171\/2021.6.FOCUS2111234469867"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/51\/3\/article-pE10.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/51\/3\/article-pE10.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/51\/3\/article-pE10.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:26:53Z","timestamp":1780734413000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/51\/3\/article-pE10.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2021.6.focus21374","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}